摘要
Abstract
Objective To evaluate the efifcacy and safety of Dengzhanshengmai capsule in the treatment of angina pectoris. Method The data based on PubMed, CNKI, CBM, Wanfang and VIP Data were retrieved for collecting the randomized controlled trials (RCT) about Dengzhanshengmai capsule treated with angina pectoris from the date of establishment of the databases to December 2013. After the critical evaluation on the quality of literature, the extracted data were analyzed by Review Manager 5.1 software. Result A total 10 pieces of RCT were discovered. Meta-analysis showed that there was statistical difference between 3 effect index in evaluating the symptoms of angina efifcacy, OR = 3.55, 95%CI:2.40 ~ 5.24, the ECG efifcacy, OR=2.43, 95%CI:1.68~3.51, and the incidence of adverse cardiac events, OR=0.34, 95%CI:0.20~0.58. Conclusion Dengzhanshengmai capsule can significantly improve the clinical condition of patients with angina pectoris, and decrease the incidence of adverse cardiac events.关键词
灯盏生脉胶囊/冠心病/心绞痛/Meta分析Key words
Dengzhanshengmai capsule/Coronary heart disease/Angina/Meta-analysis
